161 related articles for article (PubMed ID: 33108684)
41. Follicular and Hürthle cell lesions of the thyroid: can inconclusive results be minimized?
Sherman JF; Leiman G; Naud S; Nathan MH; Ambaye AB
Acta Cytol; 2008; 52(6):659-64. PubMed ID: 19068668
[TBL] [Abstract][Full Text] [Related]
42. When to repeat thyroid fine needle aspiration cytology?
Moslavac S; Matesa-Anić D; Matesa N; Kusić Z
Acta Clin Croat; 2012 Dec; 51(4):549-54. PubMed ID: 23540162
[TBL] [Abstract][Full Text] [Related]
43. Divide and rule: cytodiagnosis of thyroid lesions using pattern analysis: a study of 233 cases.
MuddeGowda PH; Lingegowda J; Natesan R; Kurpad R
Diagn Cytopathol; 2011 Dec; 39(12):888-95. PubMed ID: 22081525
[TBL] [Abstract][Full Text] [Related]
44. Value of fine-needle aspiration in the diagnosis of Hürthle cell neoplasms.
McIvor NP; Freeman JL; Rosen I; Bedard YC
Head Neck; 1993; 15(4):335-41. PubMed ID: 8360056
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
46. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
[TBL] [Abstract][Full Text] [Related]
47. Ectopic thyroid in left parotid gland with an orthotopic thyroid gland: A rare case scenario.
Singh A; Yadav K; Kumar M; Misra V
Indian J Pathol Microbiol; 2021; 64(4):780-782. PubMed ID: 34673603
[TBL] [Abstract][Full Text] [Related]
48. Intense FDG uptake in a benign Hurthle cell adenoma.
Rohren EM
Clin Nucl Med; 2004 Oct; 29(10):664-6. PubMed ID: 15365450
[No Abstract] [Full Text] [Related]
49. Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario.
Straccia P; Santeusanio G; Pierconti F; Brunelli C; Fadda G
Appl Immunohistochem Mol Morphol; 2019; 27(10):726-731. PubMed ID: 30358610
[TBL] [Abstract][Full Text] [Related]
50. Fine needle aspiration cytology of unsuspected metastatic hurthle cell carcinoma of the thyroid and its pitfalls: a report of two cases.
Lallu S; Naran S; Bethwaite P
Diagn Cytopathol; 2007 Jul; 35(7):439-43. PubMed ID: 17580356
[TBL] [Abstract][Full Text] [Related]
51. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.
Alaedeen DI; Khiyami A; McHenry CR
Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293
[TBL] [Abstract][Full Text] [Related]
52. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
[TBL] [Abstract][Full Text] [Related]
53. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
[TBL] [Abstract][Full Text] [Related]
54. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
55. Cytopathology of Hürthle cell lesions of the thyroid gland by fine needle aspiration.
Kini SR; Miller JM; Hamburger JI
Acta Cytol; 1981; 25(6):647-52. PubMed ID: 6171979
[TBL] [Abstract][Full Text] [Related]
56. Thyroid tumors: cytomorphology of Hürthle cell tumors, including an uncommon papillary variant.
Kaur A; Jayaram G
Diagn Cytopathol; 1993; 9(2):135-7. PubMed ID: 8513705
[TBL] [Abstract][Full Text] [Related]
57. Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization.
Erickson LA; Jalal SM; Goellner JR; Law ME; Harwood A; Jin L; Roche PC; Lloyd RV
Am J Surg Pathol; 2001 Jul; 25(7):911-7. PubMed ID: 11420462
[TBL] [Abstract][Full Text] [Related]
58. Immunocytochemical expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas.
Pisani T; Pantellini F; Centanni M; Vecchione A; Giovagnoli MR
Anticancer Res; 2003; 23(4):3323-6. PubMed ID: 12926070
[TBL] [Abstract][Full Text] [Related]
59. Assessment of malignancy rate in thyroid nodules according to the Bethesda system of fine-needle aspiration. Report from a tertiary center in the Southwestern region of Saudi Arabia.
Al-Shraim MM; Kaood OM; Hussein MR; Al-Ahmary AM; Al Shehri GY; Jastania RA; Mahfouz AA; Abu-Eshy SA
Saudi Med J; 2012 Feb; 33(2):167-71. PubMed ID: 22327757
[TBL] [Abstract][Full Text] [Related]
60. Hürthle cells in fine-needle aspirates of the thyroid: a review of their diagnostic criteria and significance.
Auger M
Cancer Cytopathol; 2014 Apr; 122(4):241-9. PubMed ID: 24436122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
